Lindynette 30 (Ethinylestradiol, Gestodene)

Ethinylestradiol and Gestodene, the active ingredients in Lindynette 30, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy by inhibiting ovulation and altering cervical mucus in women of reproductive age.

GNH USA supplies Lindynette 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lindynette 30, a combined oral contraceptive, is used within the hormonal birth‑control pathway to prevent pregnancy.

- Contraception: provides reliable reversible birth control for women of childbearing potential. - Menstrual cycle regulation: helps achieve more regular menstrual cycles and may reduce dysmenorrhea. - Ovarian cyst prevention: can reduce the formation of functional ovarian cysts in some users.

Lindynette 30 may cause a range of adverse reactions. Most are mild and transient, but serious events can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: discomfort or swelling. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional lability. - Spotting: irregular breakthrough bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: clot formation in leg veins. - Pulmonary embolism: blockage of lung arteries. - Stroke: cerebrovascular accident due to clot or bleed. - Hepatic adenoma: benign liver tumor. - Severe allergic reaction: anaphylaxis or angioedema. - Hypertension: significant rise in blood pressure.

Before prescribing Lindynette 30, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Assess thrombotic risk: review personal or family history of clotting disorders. - Screen for cardiovascular disease: avoid in uncontrolled hypertension or coronary artery disease. - Evaluate liver function: contraindicated in active liver disease or severe hepatic impairment. - Counsel on smoking: advise against use in women over 35 who smoke. - Review medication history: consider interactions that may reduce efficacy. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Lindynette 30 can interact with several medicines, altering its effectiveness or increasing adverse risk.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): markedly reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect and increase bleeding risk. - HIV protease inhibitors (e.g., ritonavir): can diminish hormonal levels.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., ampicillin): may slightly lower plasma hormone concentrations. - Anticonvulsants (e.g., phenytoin): may reduce contraceptive reliability. - Herbal supplements (e.g., St. John's wort): can decrease hormone levels and increase breakthrough bleeding.